(23S,24S)-spirost-5,25(27)-diene-1beta,3beta,21,23,24-pentol 1-O-alpha-L-rhamnopyranosyl-(1→2)-{beta-D-xylopyranosyl-(1→3)}-alpha-L-arabinopyranoside-24-O-beta-D-fucopyranoside - Compound Card

(23S,24S)-spirost-5,25(27)-diene-1beta,3beta,21,23,24-pentol 1-O-alpha-L-rhamnopyranosyl-(1→2)-{beta-D-xylopyranosyl-(1→3)}-alpha-L-arabinopyranoside-24-O-beta-D-fucopyranoside

Select a section from the left sidebar

(23S,24S)-spirost-5,25(27)-diene-1beta,3beta,21,23,24-pentol 1-O-alpha-L-rhamnopyranosyl-(1→2)-{beta-D-xylopyranosyl-(1→3)}-alpha-L-arabinopyranoside-24-O-beta-D-fucopyranoside

Structure
Zoomed Structure
  • Family: Plantae - Ruscaceae
  • Kingdom: Plantae
  • Class: Saponin
    • Subclass: Steroidal Saponin
Canonical Smiles O[C@H]1C[C@@H](O[C@@H]2[C@@H](C)O[C@@H]([C@H]([C@H]2O)O)O[C@@H]2[C@H](OC[C@@H]([C@H]2O)O)O[C@@H]2[C@H](O)CO[C@@H]([C@H]2O)O)[C@]2(C(=CCC3C2CC[C@]2(C3C[C@H]3C2[C@H](O)[C@@]2(O3)OCC(=C)[C@@H]([C@H]2O)O[C@H]2O[C@@H](C)[C@H]([C@H]([C@@H]2O)O)O)C)C1)C
InChI InChI=1S/C48H74O23/c1-16-13-64-48(41(60)36(16)68-43-33(56)31(54)29(52)17(2)65-43)40(59)28-26(71-48)12-23-21-7-6-19-10-20(49)11-27(47(19,5)22(21)8-9-46(23,28)4)67-37-18(3)66-44(34(57)32(37)55)70-39-30(53)24(50)14-63-45(39)69-38-25(51)15-62-42(61)35(38)58/h6,17-18,20-45,49-61H,1,7-15H2,2-5H3/t17-,18+,20+,21?,22?,23?,24-,25+,26-,27+,28?,29+,30+,31+,32+,33-,34-,35-,36-,37+,38+,39-,40-,41+,42-,43+,44+,45+,46-,47-,48-/m0/s1
InChIKey QZKQZMLUUKILDV-LWHNMPKNSA-N
Formula C48H74O23
HBA 23
HBD 13
MW 1019.1
Rotatable Bonds 8
TPSA 355.29
LogP -4.1
Number Rings 10
Number Aromatic Rings 0
Heavy Atom Count 71
Formal Charge 0
Fraction CSP3 0.92
Exact Mass 1018.46
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Beaucarnea recurvata Ruscaceae Plantae 39519

Showing of synonyms

  • Eskander J, Lavaud C, et al. (2011). Steroidal saponins from the leaves of Beaucarnea recurvata. Phytochemistry, 2011, 72(9), 946-51. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC8CCC(OC8)OC9C(OCCC9)OC1CCOCC1

Level: 4

Mol. Weight: 1019.1 g/mol

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC8CCC(OC8)OC9CCCOC9

Level: 3

Mol. Weight: 1019.1 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7CCC(OC7)OC8C(OCCC8)OC9CCOCC9

Level: 3

Mol. Weight: 1019.1 g/mol

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC8CCCOC8

Level: 2

Mol. Weight: 1019.1 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7CCC(OC7)OC8CCCOC8

Level: 2

Mol. Weight: 1019.1 g/mol

Structure

SMILES: O1CCCCC1OC2C(OCCC2)OC3CCOCC3

Level: 2

Mol. Weight: 1019.1 g/mol

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7

Level: 1

Mol. Weight: 1019.1 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7CCCOC7

Level: 1

Mol. Weight: 1019.1 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1019.1 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1019.1 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6

Level: 0

Mol. Weight: 1019.1 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1019.1 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.55
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
79911.79
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
10444405.67

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.72
Plasma Protein Binding
67.04
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
1.47
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-242907.23
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.14
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-18956091607.89
Rat (Acute)
4.12
Rat (Chronic Oral)
40.36
Fathead Minnow
23928030.06
Respiratory Disease
Safe
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
2132030373.93
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-1173.12
Log(P)
-1.34
Log S
-2.13
Log(Vapor Pressure)
-70206458.54
Melting Point
264.24
pKa Acid
-511469.88
pKa Basic
-4100.45

No predicted protein targets found for this compound.

Download SDF